Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and Alemtuzumab
Condition: Multiple Sclerosis Intervention: Biological: COVID-19 vaccination Sponsors: Sheba Medical Center; Sanofi Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials